KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Assets: 2009-2025

Historic Return on Assets for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to 0.05%.

  • Jazz Pharmaceuticals' Return on Assets rose 1.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1.00%. This contributed to the annual value of 0.05% for FY2024, which is 1.00% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Assets is 0.05%, which was up 18.08% from 0.04% recorded in Q2 2025.
  • Jazz Pharmaceuticals' Return on Assets' 5-year high stood at 0.08% during Q1 2021, with a 5-year trough of -0.04% in Q1 2022.
  • For the 3-year period, Jazz Pharmaceuticals' Return on Assets averaged around 0.03%, with its median value being 0.04% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first dropped by 11bps in 2022, then climbed by 6bps in 2023.
  • Jazz Pharmaceuticals' Return on Assets (Quarterly) stood at -0.03% in 2021, then climbed by 1bps to -0.02% in 2022, then rose by 6bps to 0.04% in 2023, then grew by 1bps to 0.05% in 2024, then grew by 1bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.04% for Q2 2025, and 0.05% during Q4 2024.